FR-115427
FR-115427 is a chemical compound that has been studied for its potential therapeutic effects, particularly in the context of neurodegenerative diseases. It is known for its role as a selective muscarinic acetylcholine receptor antagonist, which has implications in the modulation of cholinergic signaling in the brain.
Chemical Structure and Properties[edit]
FR-115427 is a synthetic compound with a complex molecular structure. It is characterized by its ability to bind selectively to certain subtypes of muscarinic receptors, which are a class of G protein-coupled receptors that play a crucial role in the parasympathetic nervous system.
Mechanism of Action[edit]
The primary mechanism of action of FR-115427 involves its antagonistic effects on muscarinic acetylcholine receptors. By inhibiting these receptors, FR-115427 can modulate the activity of acetylcholine, a neurotransmitter that is critical for various cognitive functions, including memory and learning. This makes it a compound of interest in the study of Alzheimer's disease and other cognitive disorders.
Therapeutic Potential[edit]
Research into FR-115427 has focused on its potential use in treating neurodegenerative conditions. Its ability to selectively target muscarinic receptors without affecting other types of receptors could make it a valuable tool in developing treatments that have fewer side effects compared to non-selective agents.
Research and Development[edit]
Studies have shown that FR-115427 can cross the blood-brain barrier, which is essential for any compound intended to affect central nervous system function. Preclinical trials have demonstrated its efficacy in animal models of cognitive impairment, but further research is needed to fully understand its potential in human subjects.
Safety and Side Effects[edit]
As with any pharmacological agent, the safety profile of FR-115427 is a critical consideration. While it has shown promise in early studies, comprehensive clinical trials are necessary to evaluate its safety and efficacy in humans. Potential side effects may include those common to other muscarinic antagonists, such as dry mouth, blurred vision, and constipation.
Also see[edit]
- Muscarinic acetylcholine receptor
- Cholinergic system
- Neurodegenerative disease
- Alzheimer's disease
- G protein-coupled receptor
| Pharmacomodulation | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Pharmacology | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
